PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts.\', \'Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts.\', \'Janssen Vaccines & Prevention, Leiden, the Netherlands.\', \'Janssen Research & Development, Beerse, Belgium.\', \'Harvard Medical School, Boston, Massachusetts.\', \'Massachusetts Institute of Technology, Cambridge.\', \'Massachusetts Consortium on Pathogen Readiness, Boston.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1001/jama.2021.3645
?:doi
?:hasPublicationType
?:journal
  • JAMA
is ?:pmid of
?:pmid
?:pmid
  • 33704352
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33704352>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33704352>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all